The embodiments provide prodrug compounds of Formulae I XVII. The present disclosure also provides compositions and their methods of use where the compositions comprise a prodrug compound of Formulae I XVII that provides controlled release of an active agent. Such compositions can optionally provide a trypsin inhibitor that interacts with the enzyme that mediates the controlled release of an active agent from the prodrug so as to attenuate enzymatic cleavage of the prodrug.
